Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fat Emulsions, Intravenous | 5 | 2025 | 80 | 2.720 |
Why?
|
| Parenteral Nutrition | 8 | 2025 | 216 | 2.570 |
Why?
|
| Cholestasis | 6 | 2025 | 165 | 2.400 |
Why?
|
| Soybean Oil | 7 | 2025 | 71 | 1.770 |
Why?
|
| Bile Acids and Salts | 8 | 2025 | 259 | 1.740 |
Why?
|
| Phytosterols | 3 | 2021 | 28 | 1.340 |
Why?
|
| Liver | 7 | 2025 | 1802 | 1.160 |
Why?
|
| Liver Diseases | 3 | 2023 | 381 | 1.100 |
Why?
|
| Phospholipids | 2 | 2019 | 103 | 1.060 |
Why?
|
| Fibroblast Growth Factors | 4 | 2023 | 171 | 0.920 |
Why?
|
| Swine | 13 | 2025 | 1187 | 0.850 |
Why?
|
| Biliary Atresia | 1 | 2025 | 220 | 0.710 |
Why?
|
| Emulsions | 5 | 2025 | 70 | 0.710 |
Why?
|
| Fish Oils | 3 | 2021 | 81 | 0.680 |
Why?
|
| Infant, Premature | 5 | 2023 | 855 | 0.640 |
Why?
|
| Lipid Metabolism | 3 | 2020 | 370 | 0.620 |
Why?
|
| Animals, Newborn | 7 | 2025 | 1016 | 0.620 |
Why?
|
| Vitamin E | 1 | 2019 | 63 | 0.610 |
Why?
|
| Rifampin | 1 | 2019 | 122 | 0.580 |
Why?
|
| Kupffer Cells | 1 | 2017 | 20 | 0.540 |
Why?
|
| Triglycerides | 3 | 2019 | 605 | 0.540 |
Why?
|
| Endotoxins | 1 | 2017 | 50 | 0.540 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 407 | 0.510 |
Why?
|
| Hepatocytes | 1 | 2017 | 235 | 0.480 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 685 | 0.410 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 851 | 0.370 |
Why?
|
| Hypertension | 1 | 2020 | 1356 | 0.350 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2025 | 252 | 0.340 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2025 | 326 | 0.340 |
Why?
|
| Inflammation | 1 | 2017 | 1489 | 0.320 |
Why?
|
| Intestines | 2 | 2025 | 590 | 0.310 |
Why?
|
| Animals | 15 | 2025 | 33829 | 0.290 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4647 | 0.270 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 65 | 0.270 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 2096 | 0.260 |
Why?
|
| Milk, Human | 3 | 2025 | 312 | 0.250 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2025 | 48 | 0.230 |
Why?
|
| Infant, Newborn | 7 | 2025 | 8554 | 0.210 |
Why?
|
| Citrulline | 1 | 2025 | 123 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2025 | 453 | 0.200 |
Why?
|
| beta Carotene | 1 | 2023 | 36 | 0.200 |
Why?
|
| Arginine | 1 | 2025 | 334 | 0.200 |
Why?
|
| Enteral Nutrition | 1 | 2025 | 281 | 0.200 |
Why?
|
| Endocrine System | 1 | 2022 | 18 | 0.180 |
Why?
|
| Parturition | 1 | 2022 | 63 | 0.180 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2022 | 114 | 0.180 |
Why?
|
| Hydrocortisone | 1 | 2022 | 221 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 170 | 0.170 |
Why?
|
| Humans | 15 | 2025 | 130599 | 0.170 |
Why?
|
| Intestinal Mucosa | 1 | 2025 | 767 | 0.160 |
Why?
|
| Chronotherapy | 1 | 2020 | 1 | 0.160 |
Why?
|
| Probiotics | 1 | 2023 | 226 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2022 | 4659 | 0.160 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 41 | 0.150 |
Why?
|
| Creatinine | 1 | 2021 | 397 | 0.150 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 50 | 0.150 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 63 | 0.150 |
Why?
|
| Sus scrofa | 1 | 2019 | 114 | 0.150 |
Why?
|
| Glucose | 1 | 2022 | 848 | 0.130 |
Why?
|
| Homeostasis | 1 | 2021 | 712 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 22 | 0.130 |
Why?
|
| Palmitic Acid | 1 | 2016 | 28 | 0.120 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 32 | 0.120 |
Why?
|
| Isoflavones | 1 | 2016 | 42 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 168 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 303 | 0.120 |
Why?
|
| Premature Birth | 1 | 2020 | 423 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 832 | 0.110 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 142 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 445 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 263 | 0.110 |
Why?
|
| Child Development | 1 | 2017 | 271 | 0.110 |
Why?
|
| Risk Factors | 2 | 2020 | 10991 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 214 | 0.100 |
Why?
|
| Infant Formula | 2 | 2025 | 103 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2016 | 378 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 366 | 0.100 |
Why?
|
| Sepsis | 1 | 2017 | 496 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2902 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1247 | 0.090 |
Why?
|
| Biomarkers | 1 | 2021 | 3395 | 0.090 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 620 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2337 | 0.070 |
Why?
|
| Female | 5 | 2025 | 70540 | 0.060 |
Why?
|
| Male | 3 | 2025 | 64580 | 0.060 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2025 | 19 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 167 | 0.060 |
Why?
|
| Pregnancy | 3 | 2022 | 7495 | 0.050 |
Why?
|
| Zeaxanthins | 1 | 2023 | 8 | 0.050 |
Why?
|
| Lutein | 1 | 2023 | 14 | 0.050 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 57 | 0.050 |
Why?
|
| Carotenoids | 1 | 2023 | 78 | 0.050 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2021 | 32 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12901 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 207 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 24 | 0.040 |
Why?
|
| Gestational Age | 1 | 2022 | 1228 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 435 | 0.030 |
Why?
|
| Oleic Acid | 1 | 2016 | 17 | 0.030 |
Why?
|
| Genistein | 1 | 2016 | 39 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 89 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 548 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3349 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 708 | 0.030 |
Why?
|
| Infant | 1 | 2023 | 13302 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4689 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3209 | 0.020 |
Why?
|